Brain Protein 14-3-3γ May Hold the Key to Preventing Post-Surgery Cognitive Decline
A protein that shields against tau hyperphosphorylation could explain why some patients lose cognitive function after surgery.
Summary
Some older adults lose cognitive sharpness after major surgery, and no reliable blood test predicts who. Researchers searched spinal fluid proteins in an Alzheimer's cohort and found 14-3-3γ stood out. In 213 older surgical patients, blood levels of 14-3-3γ were associated with postoperative cognitive dysfunction and delirium. In mice, anesthesia and surgery lowered 14-3-3γ in the hippocampus, increased Tau phosphorylation at one site (Thr205), damaged synapses, and impaired memory. Restoring 14-3-3γ reversed these problems. A small molecule, fusicoccin-A, that stabilizes the 14-3-3γ–Tau bond also improved cognition, but not when Tau was engineered to mimic Thr205 phosphorylation. The work suggests 14-3-3γ could serve as both a risk marker and a treatment target, though the human surgical findings rest on very few cognitive dysfunction cases.
Detailed Summary
Postoperative cognitive dysfunction (POCD) is a common complication in older adults. It is linked to longer hospital stays, loss of independence, and higher mortality, yet only a subset of patients is affected. No biomarker has been validated to explain who is vulnerable. Because surgical stress and anesthesia resemble early Alzheimer's-type changes, including Tau hyperphosphorylation and synapse loss, the authors looked for a shared upstream regulator.
They began with cerebrospinal fluid (CSF) proteomics from the Alzheimer's Disease Neuroimaging Initiative. Using the SomaScan 7K platform, they analyzed 7,008 analytes in 237 participants (152 with "neurodegeneration-enriched cognitive vulnerability," or NECV, and 85 cognitively normal controls). NECV was defined as mild cognitive impairment plus prior surgery. It is an exploratory phenotype, not a POCD diagnosis. Models adjusted for age, sex, education, and APOE ε4 and applied Bonferroni correction across 6,361 proteins. 14-3-3γ (YWHAG) emerged as a top candidate linked to neurodegenerative progression.
The team then enrolled 213 consecutive patients aged 65 or older undergoing major cardiac, orthopedic, or aortic surgery at one Chinese tertiary hospital. Eleven patients developed POCD and 22 developed postoperative delirium (POD). Those with POCD were older (median 77 vs 71 years, p=0.004) and had more hypertension (90.9% vs 57.4%, p=0.03) and coronary artery disease (72.7% vs 38.6%, p=0.031). They also had longer anesthesia (380 vs 322 minutes, p=0.038) and lower eGFR (p=0.042). Delirium was more tied to kidney and heart disease, longer anesthesia (450 vs 315 minutes, p<0.001), and greater blood loss. The authors report that plasma 14-3-3γ levels were associated with both outcomes.
In mice, anesthesia and surgery reduced hippocampal 14-3-3γ. Among the Tau sites examined, phosphorylation at Thr205 increased, along with synaptic dysfunction and cognitive impairment. Neuronal overexpression of 14-3-3γ rescued these deficits. 14-3-3γ bound Tau in a phosphorylation-dependent way and helped keep Tau phosphorylation balanced. The study also examined CDK5, GSK3β, and PP2A signaling, and molecular dynamics simulations supported the interaction model.
The small molecule fusicoccin-A (FC-A) stabilizes 14-3-3 protein interactions. It lowered Tau Thr205 phosphorylation and improved cognition after surgery. Expressing a phosphomimetic TauT205E diminished the benefit, which suggests that Thr205 phosphorylation is an important mediator.
The findings point to 14-3-3γ as a possible risk marker and treatment target for perioperative cognitive decline. Important caveats apply. The human cohort had only 11 POCD cases, and neither the proteomic discovery nor the surgical cohort was a formal sample-size-powered design. NECV is not true POCD, and mouse rescue does not guarantee human benefit. The provided text does not include the full results, so effect sizes for plasma 14-3-3γ are not reported here.
Key Findings
- CSF proteomics in 237 ADNI participants (152 NECV, 85 controls; 7,008 analytes) identified 14-3-3γ as a candidate marker of neurodegeneration-enriched cognitive vulnerability
- In the prospective surgical cohort (n=213, age ≥65), 11 patients developed POCD and 22 developed postoperative delirium
- Patients with POCD were older (median 77 vs 71 years, p=0.004) and had more hypertension (90.9% vs 57.4%, p=0.03) and coronary artery disease (72.7% vs 38.6%, p=0.031)
- Delirium patients had longer anesthesia (median 450 vs 315 min, p<0.001) and lower eGFR (58.3 vs 83.4 mL/min/1.73 m², p<0.001)
- In mice, surgery and anesthesia lowered hippocampal 14-3-3γ and raised Tau Thr205 phosphorylation alongside synaptic dysfunction and cognitive impairment
- Neuronal 14-3-3γ overexpression rescued synaptic and cognitive deficits in the mouse surgery model
- Stabilizing the 14-3-3γ–Tau interaction with fusicoccin-A reduced Thr205 phosphorylation and improved cognition, an effect diminished by phosphomimetic TauT205E
Methodology
The study combined an exploratory ADNI CSF proteomic discovery analysis (n=237, SomaScan 7K, multiple linear regression adjusted for age, sex, education, and APOE ε4, Bonferroni-corrected), validation in PPMI and postmortem AD samples, and Cox/Kaplan–Meier progression analyses. A single-center prospective surgical cohort of 213 patients aged 65 or older (ChiCTR2500096293) assessed POCD and POD, with groups compared by Wilcoxon, chi-square, or Fisher tests. Mechanistic work used a murine surgery model, AAV-mediated gene manipulation, neuronal cultures, pharmacological intervention with FC-A, and molecular dynamics simulations. No formal sample-size calculation was performed.
Study Limitations
Only 11 patients developed POCD, and 22 developed delirium, in a single-center cohort without formal sample-size calculation, limiting statistical power and generalizability. The ADNI NECV phenotype is exploratory and cannot confirm POCD, because perioperative details were unavailable. Mouse findings, including the FC-A rescue, may not translate to humans, and the study's disclosed conflicts of interest were not available in the supplied text.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: